Form 4: Baxter CFO Joel Grade's Equity Award Vesting
Insider Transaction Report
Baxter International's EVP and CFO, Joel T. Grade, reported the vesting of performance share units and subsequent tax-related share forfeiture.
Summary
- Joel T. Grade, Executive Vice President and Chief Financial Officer of Baxter International Inc. (BAX), reported changes in his beneficial ownership.
- Mr. Grade acquired 30,504 shares of common stock on February 9, 2026, resulting from the vesting of performance share units (PSUs).
- These PSUs were granted on March 1, 2023, under the Amended & Restated Baxter International Inc. 2021 Incentive Plan.
- The vesting was based on Baxter's performance against Sales Compound Annual Growth Rate (Sales CAGR), Total Shareholder Return (TSR), and Total Return on Invested Capital (ROIC) targets over the three-year period from January 1, 2023, to December 31, 2025.
- Concurrently, Mr. Grade disposed of 9,144 shares at a price of $21.73 per share to cover tax withholding obligations incurred due to the PSU vesting.
- Following these transactions, Mr. Grade's direct beneficial ownership stands at 236,904 shares, which includes shares from automatic dividend reinvestment and the Baxter Employee Stock Plan.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this filing as moderately positive. While a routine compensation event, the vesting of PSUs confirms that Baxter met its performance targets over a three-year period, which is a positive indicator of past operational success.
Positives
- The vesting of 30,504 performance share units indicates that Baxter International met its performance targets related to Sales CAGR, TSR, and ROIC for the 2023-2025 period, reflecting positive operational and financial execution.
- The equity award structure aligns executive incentives with long-term company performance and shareholder value creation.
Negatives
- The forfeiture of 9,144 shares to cover tax obligations, while a standard practice, reduces the executive's direct shareholding post-vesting.
Future Outlook
This Form 4 filing does not contain specific forward-looking statements or guidance regarding Baxter International's future performance.
Industry Context
StockSavvy.ai notes that the vesting of performance share units for executive compensation is a standard practice in the healthcare and medical device industry. This mechanism is designed to align the interests of executives with those of shareholders by tying a portion of their compensation to the company's achievement of pre-defined financial and operational targets.
Comparison to Industry Standards
- Executive equity compensation, structured with performance share units tied to specific financial metrics like Sales CAGR, TSR, and ROIC, is a common and widely accepted practice across large-cap pharmaceutical and medical device companies, including peers like Medtronic (MDT) or Abbott Laboratories (ABT). This structure aims to align executive incentives with long-term shareholder value creation.
- The forfeiture of shares to cover tax liabilities upon vesting is also a standard and routine procedure for equity compensation in the industry.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Reference | The transactions are pursuant to the Amended & Restated Baxter International Inc. 2021 Incentive Plan and the Annual Equity Program adopted by Baxter International Inc. | Not applicable (plan already in effect) | Reinforces the company's established framework for executive equity compensation, aligning management incentives with company performance. |
Stakeholder Impact
- Shareholders: The vesting of performance-based equity awards suggests that the company achieved its strategic and financial objectives, which generally benefits shareholders through improved performance and aligned management incentives.
- Employees: The existence of an Employee Stock Plan, as referenced in the beneficial ownership total, indicates opportunities for broader employee participation in company ownership.
Key Dates
| Date | Description |
|---|---|
| 03/01/2023 | Date of grant for the performance share unit award (2023 PSUs). |
| 01/01/2023 | Start of the three-year performance period for the 2023 PSUs. |
| 12/31/2025 | End of the three-year performance period for the 2023 PSUs. |
| 02/09/2026 | Transaction date for the acquisition of shares from PSU vesting and disposition of shares for tax withholding. |
| 02/11/2026 | Date the Form 4 was signed. |
Recommendation
holdThis Form 4 filing reports a routine, pre-scheduled executive compensation event (vesting of PSUs and tax-related share forfeiture). While it confirms past performance targets were met, it does not provide new fundamental information that would significantly alter the investment thesis for Baxter International. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not warrant a change in investment strategy.
Keywords
Baxter International, BAX, Form 4, Insider Transaction, Executive Compensation, Performance Share Units, Equity Award, Vesting, Joel T. Grade, CFO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.